Durgical
EN
Open the app

Atogepant

  • CGRP antagonists (gepants and anti-CGRP antibodies)CGRP antagonists (gepants and anti-CGRP antibodies)

An oral CGRP receptor blocker taken every day to prevent migraine. It does not treat an attack that has already started.

Updated

Quick facts

Group
CGRP antagonists (gepants and anti-CGRP antibodies)
Target
CGRP receptor (calcitonin receptor-like receptor, CALCRL, with RAMP1)
Used for
Prevention of migraine in adults
Key effects
Nausea · Constipation · Decreased appetite
Monitor
Blood pressure at follow-up
ATC
N02CD07

No doses: the clinician sets them by the current guideline.

Mechanism of action

The figure shows telcagepant, an earlier gepant that was never marketed, bound to the extracellular domains of the human CGRP receptor (CLR with RAMP1), where small-molecule gepants block the receptor; there is no structure with this drug.

Target in 3D: CGRP receptor (calcitonin receptor-like receptor, CALCRL, with RAMP1). PDB structure 3N7R (RCSB PDB, public domain). View the structure at RCSB PDB

Atogepant is a small-molecule antagonist of the CGRP receptor (a gepant). Calcitonin gene-related peptide (CGRP), released by trigeminal nerves during migraine, dilates meningeal vessels and drives neurogenic inflammation. Gepants bind at the junction of the two receptor subunits (CLR and RAMP1) and stop CGRP from activating it. Unlike triptans, they do not constrict blood vessels.

  1. Atogepant blocks the CGRP receptor every day
  2. Trigeminal CGRP signalling stays damped
  3. Fewer migraine days over time

Indications

Adverse effects

Common

  • Nausea
  • Constipation
  • Decreased appetite
  • Tiredness and sleepiness

Contraindications

  • Hypersensitivity to atogepant or any component of the product

Key interactions

St John's wort
Can lower atogepant levels
Grapefruit and grapefruit juice
Their use is discussed with the treating team
Acute migraine medicines
Still needed for attacks: atogepant only prevents them

What is monitored

  • Blood pressure at follow-up
  • Fingers and toes for Raynaud symptoms
  • Headache diary to judge the benefit

Administration and safety

  • Oral tablet once a day at about the same time
  • Not stopped without talking to the treating team

Pregnancy and breastfeeding

There is little information in pregnancy; it is a decision for the treating team.

Nursing care

  • Measure blood pressure before starting and at visits
  • Ask about Raynaud phenomenon, kidney and liver disease
  • Teach the warning signs of high blood pressure: severe headache, chest pain, vision changes

Pharmacokinetics

Absorption
Oral tablet once a day, with or without food

Test yourself

Think of the answer, then tap the question to see it.

Is atogepant used to treat a migraine attack in progress?

No; it is a daily preventive medicine.

Which two vascular problems are watched for with atogepant?

High blood pressure and Raynaud phenomenon.

Which receptor does atogepant block?

The CGRP receptor (CLR with RAMP1).

Add to my cards (3)

More Pharmacology questions →

Connections

← Back to the class: CGRP antagonists (gepants and anti-CGRP antibodies)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Atogepant: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026); RCSB PDB - 3N7R: Crystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site of drug antagonism (RCSB Protein Data Bank, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.